期刊文献+

血清唾液酸浓度与2型糖尿病患者全视网膜光凝术后黄斑水肿的关系

Relationship between Serum Sialic Acid Concentration and Macular Edema in Patients with Type 2 Diabetes Mellitus Treated with Panretinal Photocoagulation
下载PDF
导出
摘要 目的:探讨2型糖尿病患者血清唾液酸浓度与全视网膜激光光凝术后糖尿病性黄斑水肿的相关性。方法:选取102例2型糖尿病患者,糖尿病视网膜病变分级均为III^IV期,激光治疗前均无黄斑水肿病变。由同一医生分4次进行全视网膜激光光凝治疗,观察激光治疗后黄斑水肿情况。采取外周静脉血后用比色法测量血清唾液酸浓度,用视网膜血管荧光造影方法判断黄斑区水肿程度。结果:102例糖尿病患者平均血清唾液酸浓度为106.65 &#177;10.21 mmol/l,激光治疗后发生糖尿病性黄斑水肿的患者为22例,其中1级水肿10例,2级水肿5例,3级水肿7例。未发生黄斑水肿的患者血清唾液酸浓度为96.33 &#177;10.39 mmol/l,发生黄斑水肿的患者中血清唾液酸浓度为120.01 &#177;17.71 mmol/l,两者差异具有统计学意义(P <0.05)。血清唾液酸浓度与黄斑水肿严重程度有显著正相关(r = 0.68, P <0.05)。结论:2型糖尿病患者血清唾液酸浓度与视网膜激光光凝术后黄斑水肿的发生密切相关。
出处 《眼科学》 2016年第3期77-80,共4页 Hans Journal of Ophthalmology
基金 深圳市科技研发资金资助项目,项目编号JCY201304011113593。
  • 相关文献

参考文献2

二级参考文献50

  • 1Duncan BB, Sehmidt M, Pankow JS. Low grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. ADA ,2003 ;52 : 1799-1805.
  • 2Soedamah- Muthu SS, Chaturvedi N, Pickup JC, Fuller JH. Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study ( PCS ). Diabetologia ,2008 ;51:493-501.
  • 3Soedamah- Muthu SS, Fuller JH, Mulnier HE. High risk of cardiovascular disease in patients with type 1 diabetes in the U. K. : acohort study using the general practice research database. Diabetes Care ,2006; 29:798-804.
  • 4Knuiman MW, Watts GF, Divitini ML. Is sialic acid an independent risk factor for cardiovascular disease.'? A 17- year follow- up study in Busselton, Western Australia. Ann Epidemiol ,2004 ; 14:627-632.
  • 5Laing SP, Swerdlow AJ, Slater SD. Mortality from heart disease in a cohort of 23,000 patients with insulin- treated diabetes. Diabetologia ,2003 ;46:760-765.
  • 6Browning LM, Jebb SA, Mishra GD. Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women. Int J Obes Relat ,2004 ;28:1004-1010.
  • 7Rahman I, Malik SA, Bashir M, Khan R, Iqbal M. Serum sialic acid changes in non - insulin - dependant diabetes mellitus ( NIDDM ) patients following bitter melon( Momordica charantia) and rosiglitazone (Avantia) treatment. Phytomedicine ,2009 ; 16 : 401-405.
  • 8Sabzwari M J, Ahmad M, Majeed MT, Riaz M, Umair M. Serum Sialic acid concentration and type 2 diabetes me|litus. Professional Med J ,2006 ; 13(4) :508-510.
  • 9Khurshld MU, Us I. Sialic acid as a predictor of type 2 diabetes mellitus. Professional Med J ,2008 ; 15 ( 2 ) :273-275.
  • 10Crook MA, Khanhadia S, Lumb P, Ridha A, Hussain A. No differences in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathy. Diabetes Res Clin Pract ,2000 ;47 : 147-150.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部